Upstream Bio (UPB) Assets Average (2024 - 2026)

Upstream Bio's Assets Average history runs 3 years deep, the most recent figure standing at $335.9 million for Q1 2026.

• In Q1 2026, Assets Average fell 28.37% year-over-year to $335.9 million; the TTM figure through Mar 2026 stood at $335.9 million (down 28.37% YoY), while the FY2025 annual figure was $417.7 million, up 39.5% from the prior year.
• Assets Average for Q1 2026 stood at $335.9 million, down from $372.5 million in the prior quarter.
• The five-year high for Assets Average was $468.9 million in Q1 2025, with the low at $335.9 million in Q1 2026.
• The 3-year median for Assets Average is $389.2 million (2025), against an average of $396.5 million.
• The sharpest annual moves came in 2025 and 2026: Assets Average climbed 4.28% in 2025, then slipped 28.37% in 2026.
• Upstream Bio's Assets Average stood at $357.2 million in 2024, then climbed by 4.28% to $372.5 million in 2025, then retreated by 9.82% to $335.9 million in 2026.
• Business Quant data shows UPB's Assets Average at $335.9 million in Q1 2026, $372.5 million in Q4 2025, and $405.9 million in Q3 2025.